Skip to Content

ClinPhone and LabPas CT Agree to Interface

MONTPELIER, Vermont, July 30, 2007 – ClinPhone, a leading specialist provider of technology solutions to the clinical trials industry has agreed to develop an interface between its EDC product and LabPas CT, the leading software solution for Phase I clinical trials according to Green Mountain Logic, developer of LabPas CT.

An interface between ClinPhone EDC (formerly known as DataLabs Clinical) and LabPas CT will reduce the cost and duration of Phase I clinical trials, while also improving the accuracy, integrity and consistency of the data collected. In addition, both ClinPhone EDC and LabPas CT are highly regarded in the industry for their ease of use.

John Rosenblum, Green Mountain Logic CEO stated, “I am delighted to announce this agreement between ClinPhone and Green Mountain Logic, two leaders in their respective fields with products designed for intuitive use.”

About ClinPhone ClinPhone Group, based in Nottingham, England was founded in 1993, and is recognized as the leading Clinical Technology Organization (CTO). Using a unique combination of internet-powered and telecommunications technology, coupled with vast clinical experience, ClinPhone has developed applications for the majority of the world’s Pharmaceutical and Biotechnology organizations. ClinPhone EDC is a single data management system that unifies the capabilities and functionality of paper data entry into one, easy-to-use platform. This powerful electronic system allows users to design a clinical study once, then collect, query, clean and manage clinical data using either an electronic or paper-based workflow. Additional information about ClinPhone is available at About Green Mountain Logic and LabPas CT Green Mountain Logic, located in Montpelier, Vermont, provides powerful, reliable, easy to use, targeted technology solutions to the life science industry. GML’s LabPas CT product comprehensively manages Phase I clinical trials, from recruiting through export to EDC. Unique in its intuitive use and adaptability to individual study protocols, LabPas CT increases margins, improves compliance and expands capabilities. In the last year, seven highly regarded CROs have selected LabPas CT to automate their Phase I studies.

Posted: July 2007